Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 26th June. Click Here for more information.

Source: The post is based on the article Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member published in “PIB” on 14th October 2023

What is the News?

Indian Pharmacopoeia Commission (IPC) has joined as a member of the Pharmacopoeial Discussion Group(PDG).

IPC officially joined as a member of PDG at the PDG’s Annual Meeting in Hyderabad.

What is the Indian Pharmacopoeia Commission(IPC)?

Click Here to read

What is Pharmacopoeial Discussion Group(PDG)?

PDG was established in 1989 by the European Union(EU), Japan and United States Pharmacopeial Convention. 

The World Health Organization joined it as an observer in 2001.

Objective: To reduce the challenges faced by drug manufacturers who have to conduct tests differently and meet various quality standards to comply with drug regulations that vary from country to country.

What are the benefits of the Indian Pharmacopoeia Commission joining Pharmacopoeial Discussion Group(PDG)?

Enhances the international visibility and recognition of the Indian Pharmacopoeia.

Leads to the production of high-quality pharmaceutical products that meet global standards benefiting both domestic and export markets.

Will enable the Indian Pharmacopoeia commission to collaborate and align pharmacopoeial standards with major international regulatory authorities.

Helps improve the acceptance of Indian medicinal products in global markets.

Helps reduce trade barriers and facilitate the global trade of pharmaceutical products.

Print Friendly and PDF
Blog
Academy
Community